US 11234976
Methods of using pyruvate kinase activators
granted A61KA61K31/496A61P
Quick answer
US patent 11234976 (Methods of using pyruvate kinase activators) held by Agios Pharmaceuticals, Inc. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/496, A61P, A61P7/06